TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Egetis Therapeutics AB (publ)
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 15,102 | 27,808 | 30,137 |
Financial expenses | 468 | 137 | 659 |
Earnings before taxes | -129,504 | -76,016 | -132,757 |
EBITDA | -130,573 | -75,059 | -131,927 |
Total assets | 374,946 | 413,933 | 662,573 |
Current assets | 98,498 | 111,180 | 222,253 |
Current liabilities | 33,011 | 28,482 | 51,986 |
Equity capital | 338,260 | 383,227 | 466,655 |
- share capital | 7,551 | 6,317 | 6,439 |
Employees (average) | 15 | 11 | 9 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 90.2% | 92.6% | 70.4% |
Turnover per employee | 1,007 | 2,528 | 3,349 |
Profit as a percentage of turnover | -857.5% | -273.4% | -440.5% |
Return on assets (ROA) | -34.4% | -18.3% | -19.9% |
Current ratio | 298.4% | 390.4% | 427.5% |
Return on equity (ROE) | -38.3% | -19.8% | -28.4% |
Change turnover | -10,453 | -1,759 | -31,055 |
Change turnover % | -41% | -6% | -51% |
Chg. No. of employees | 4 | 2 | 0 |
Chg. No. of employees % | 36% | 22% | 0% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.